Clinical study to see the effect of vasadi dashang ghan vati in 60 patients having urdhwag amlapitta (Gastro oesophagial Reflux Disease)

An open randomized controlled clinical study of efficacy of vasadi dashang ghan vati in the management of urdhwag amlapitta - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075604

Enrollment

Registered

2024-10-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.All sex 2.Age 18-80 years 3.Patients presenting with Lakshanas of amlapitta

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Participant those are k/c/o chronic alcohol addiction 3.Not willing for trial or non-cooperative patients 4.Patients those are k/c/o HIV, HbsAg 5.Patients who are on steroid, non-steroid anti-inflammatory drugs.

Design outcomes

Primary

Measure	Time frame
Decrease in symptoms of urdhwag amlapittaTimepoint: 21 days	—

Secondary

Measure	Time frame
1. Avipak (Indigestion) 2. Klama (tiredness) 3. Utklesha (Nausea) 4. Tikta-mlodgar (sour and bitter belching). 5. Gaurav (Heaviness in the body) 6. Hrit-Kantha daha (Burning sensation at epigastrium and chest) 7. Aruchi (Anorexia)Timepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Hemant Paradkar

APMs Ayurved Mahavidyalaya Sion Mumbai

hemant.paradkar@gmail.com9987519315

Outcome results